Variant report
Variant | esv3383860 |
---|---|
Chromosome Location | chr6:65698581-65700729 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140557012 | chr6:65698583-65698584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551235370 | chr6:65698622-65698623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191041048 | chr6:65698633-65698634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9363306 | chr6:65698750-65698751 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs182063715 | chr6:65698753-65698754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565357987 | chr6:65698765-65698766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9363307 | chr6:65698830-65698831 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs554278210 | chr6:65698837-65698838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568221663 | chr6:65698841-65698842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186037255 | chr6:65698927-65698928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs72875947 | chr6:65698962-65698963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548258816 | chr6:65698976-65698977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546123663 | chr6:65699015-65699016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376933650 | chr6:65699039-65699040 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566493111 | chr6:65699072-65699073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553375372 | chr6:65699082-65699083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149998174 | chr6:65699101-65699102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9345578 | chr6:65699119-65699120 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs373148243 | chr6:65699196-65699197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146584388 | chr6:65699199-65699200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190925969 | chr6:65699204-65699205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs71553508 | chr6:65699286-65699287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs67811515 | chr6:65699288-65699289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72077653 | chr6:65699299-65699300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183192300 | chr6:65699309-65699310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs13205619 | chr6:65699310-65699311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2349997 | chr6:65699311-65699312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141186637 | chr6:65699312-65699313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372288581 | chr6:65699356-65699357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549850886 | chr6:65699375-65699376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188073748 | chr6:65699466-65699467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145020013 | chr6:65699490-65699491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552728149 | chr6:65699505-65699506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546902805 | chr6:65699516-65699517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565319078 | chr6:65699664-65699665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138879468 | chr6:65699693-65699694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs3033931 | chr6:65699694-65699695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9345579 | chr6:65699696-65699697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540972262 | chr6:65699717-65699718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs70999183 | chr6:65699719-65699720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9345580 | chr6:65699723-65699724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs369984295 | chr6:65699725-65699726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9354198 | chr6:65699727-65699728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs66591902 | chr6:65699781-65699782 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs548263297 | chr6:65699834-65699835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138747548 | chr6:65699852-65699853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537158452 | chr6:65699868-65699869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538108612 | chr6:65699876-65699877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2349996 | chr6:65699896-65699897 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs570682322 | chr6:65699929-65699930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65697000-65698600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:65697600-65699000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr6:65697600-65700000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:65698200-65698800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr6:65698200-65699200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr6:65698200-65705000 | Weak transcription | Pancreas | Pancrea |
7 | chr6:65698800-65699000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr6:65699000-65699200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:65699000-65700400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr6:65700000-65700400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:65700400-65700600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr6:65700400-65700800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |